ReviewCurrent hematologic malignancy reports2026

Beyond Survival: Measuring Treatment Tolerability with Patient-Reported Outcomes in the Lymphoma Immunotherapy Era.

Elisa Hofmeister et al.PubMed ↗Publisher ↗

No numbers read from the abstract.